Business

January 13, 2014

Salix shares hit 52-week high

Shares of Salix Pharmaceuticals rose to a 52-week high Monday after the company announced upbeat projections in the wake of its recent acquisition of specialty drug company Santarus.

Related content

Comments

Editor's Choice Videos